US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Kronos Bio Inc (KRON)
Kronos Bio Inc (KRON) ニュース

KRON

Kronos Bio (KRON)

Kronos Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KRON

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	05 : 15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:KRON	Kronos Bio Inc
2024/05/21	21 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/05/21	21 : 15	GlobeNewswire Inc.	Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer	NASDAQ:KRON	Kronos Bio Inc
2024/05/10	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/05/10	05 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRON	Kronos Bio Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	Kronos Bio Reports First-Quarter 2024 Financial Results	NASDAQ:KRON	Kronos Bio Inc
2024/04/25	05 : 01	GlobeNewswire Inc.	Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:KRON	Kronos Bio Inc
2024/03/21	20 : 05	GlobeNewswire Inc.	Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results	NASDAQ:KRON	Kronos Bio Inc
2024/03/08	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/03/08	06 : 05	GlobeNewswire Inc.	Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway	NASDAQ:KRON	Kronos Bio Inc
2024/03/06	06 : 44	GlobeNewswire Inc.	Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting	NASDAQ:KRON	Kronos Bio Inc
2024/03/05	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/02/28	06 : 05	GlobeNewswire Inc.	Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10 : 06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10 : 03	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/01/25	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/01/06	08 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/01/06	08 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/01/06	08 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2023/12/19	06 : 06	GlobeNewswire Inc.	Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	NASDAQ:KRON	Kronos Bio Inc
2023/12/14	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2023/12/14	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2023/12/04	22 : 00	GlobeNewswire Inc.	Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	NASDAQ:KRON	Kronos Bio Inc
2023/11/28	06 : 05	GlobeNewswire Inc.	Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference	NASDAQ:KRON	Kronos Bio Inc
2023/11/14	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2023/11/14	06 : 05	GlobeNewswire Inc.	Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results	NASDAQ:KRON	Kronos Bio Inc
2023/11/14	06 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRON	Kronos Bio Inc
2023/11/03	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc

Showing the most relevant articles for your search:NASDAQ:KRON

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Yen

Gold vs US Dollar

Verizon Communications

Bank of America

Financial Select Sector

Health Care Select Sector

US Dollar vs Euro

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約